Laboratory Test Detail

Last Updated: September 18, 2019 @ 9:13 am

1001

Prenatal Panel I

Specimen:Collect:
  • One Lavender (EDTA)
  • One Pink Top (EDTA)
  • One SST
Submit:
  • 4 mL (Min:1 mL) Whole blood in Lavender (EDTA). Submit Refrigerated.
  • 6 mL (Min:3 mL) Whole blood in Pink Top (EDTA). Submit Refrigerated.
  • 3 mL (Min:2 mL) Serum . Submit Refrigerated. Submit in a Standard Transport Tube.
Special Handling:
  • See Individual Components for Special Handling and Alternate Sample Types
  • Label blood bank specimen with patient's full name and second identifier such as medical record number, DOB or SS#. Include date, time, and phlebotomist's initials.
    For patients receiving therapy with high biotin doses (>5 mg/day), no laboratory test specimen should be collected until at least 8 hours after the last biotin administration.
Methodology:
  • See Individual Components
Performed:Mon-Fri
Reported:1-3 Day(s)
CPT Codes:
  • 85025
  • 86762
  • 86780
  • 86850
  • 86900
  • 86901
  • 87340
Interpretive Data:Please see report for interpretive data.

HBsAg INTERPRETIVE NOTES:
NEGATIVE: No Evidence of Active (Acute or Chronic) Hepatitis B Virus Infection.
POSITIVE: Consistent With Active (Acute or Chronic) Hepatitis B Virus Infection. Patient Is Infective For Hepatitis B.

RUBELLA IgG INTERPRETIVE NOTES:
NOT IMMUNE: Presumed non-immune to Rubella infection.
IMMUNE: Is an indication of previous exposure to the virus either by prior infection or by vaccination.
The Rubella IgG cut-off value has been set at 10 IU/mL based on the recommendation of the Clinical and Laboratory Standards Institute subcommittee on Rubella Serology.

When the TREPONEMAL AB TOT test is reactive, it will reflex to RPR. If the RPR is non-reactive, it will then reflex to the TREPONEMAL AB IgG test for confirmation. When interpreting these results, consider the patient's history of prior infections and treatment and the patient's risk of re-infection. If diagnosis is still unclear, recommend re-testing in 2-4 weeks.

Biotin in specimens taken from patients on high-dose biotin therapy or supplements may intefere with at least one test in this panel and cause inaccurate test results. It is recommended that for patients receiving therapy with high biotin doses (> 5 mg/day), no laboratory test specimen should be taken until at least 8 hours after the last biotin administration.
Components:
  • 3806 - ABO
  • 3807 - RH
  • 3810 - ANTIBODY SCREEN
  • 3010 - WBC
  • 3015 - RBC
  • 3020 - HEMOGLOBIN
  • 3025 - HEMATOCRIT
  • 3030 - MCV
  • 3045 - RDW
  • 3035 - MCH
  • 3040 - MCHC
  • 3510 - PLATELET COUNT
  • 3054 - NEUTROPHILS
  • 3052 - LYMPHOCYTES
  • 3058 - MONOCYTES
  • 3060 - EOSINOPHILS
  • 3062 - BASOPHILS
  • 3056 - BANDS
  • 3075 - OTHER
  • 2340 - RUBELLA
  • 1003 - TREPONEMAL AB TOT
  • 2103 - HBsAg
Print Friendly, PDF & Email

Disclaimer:
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date.
Updated test information can only be guaranteed by using this website.